Opthea Ownership

Stocks . USA . 
Stock . Opthea
OPT Stock  USD 3.18  0.11  3.58%   
Opthea owns a total of 153.91 Million outstanding shares. Roughly 96.32 pct. of Opthea outstanding shares are held by general public with 3.68 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Dividend Yield is likely to drop to 0 in 2025. Dividend Payout Ratio is likely to gain to -0.04 in 2025. Common Stock Shares Outstanding is likely to drop to about 46.6 M in 2025. Net Loss is likely to gain to about (121.9 M) in 2025.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opthea. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more information on how to buy Opthea Stock please use our How to Invest in Opthea guide.

Opthea Stock Ownership Analysis

The company recorded a loss per share of 2.25. Opthea had not issued any dividends in recent years. The entity had 5:8 split on the 15th of October 2020. Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia. Opthea operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. To find out more about Opthea contact MAICD MAICD at 61 3 9826 0399 or learn more at https://opthea.com.
Besides selling stocks to institutional investors, Opthea also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Opthea's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Opthea's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Opthea Quarterly Liabilities And Stockholders Equity

188.79 Million

Opthea Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Opthea is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Opthea backward and forwards among themselves. Opthea's institutional investor refers to the entity that pools money to purchase Opthea's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Frazier Financial Advisors, Llc2024-09-30
0.0
Royal Bank Of Canada2024-09-30
0.0
Jane Street Group Llc2024-12-31
0.0
Bank Of Montreal2024-09-30
0.0
Bmo Capital Markets Corp.2024-09-30
0.0
Stratos Wealth Partners, Ltd2024-12-31
0.0
Victory Capital Management Inc.2024-09-30
0.0
Teacher Retirement System Of Texas2024-09-30
0.0
Vgi Partners Pty Ltd2024-12-31
2.9 M
Baker Bros Advisors Lp2024-12-31
2.2 M
Hsbc Holdings Plc2024-12-31
142.5 K
Note, although Opthea's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Opthea Outstanding Bonds

Opthea issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Opthea uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Opthea bonds can be classified according to their maturity, which is the date when Opthea has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Opthea Corporate Filings

6K
3rd of March 2025
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
13A
14th of November 2024
An amended filing to the original Schedule 13G
ViewVerify

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Opthea Stock Analysis

When running Opthea's price analysis, check to measure Opthea's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Opthea is operating at the current time. Most of Opthea's value examination focuses on studying past and present price action to predict the probability of Opthea's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Opthea's price. Additionally, you may evaluate how the addition of Opthea to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY